Cargando…

Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level

PURPOSE: Colitis is a common and serious complication of chronic granulomatous disorder (CGD) and requires assessment. Colonoscopy is invasive and carries risks of serious complication. We therefore assessed non-invasive monitoring via magnetic resonance imaging (MRI). We also evaluated fecal calpro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowe, David M., Smith, Philip J., Moreira, Fernando, Workman, Sarita, Braggins, Helen, Koukias, Nikolaos, Buckland, Matthew S., Wylie, Peter, Taylor, Stuart A., Murray, Charles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611758/
https://www.ncbi.nlm.nih.gov/pubmed/31172380
http://dx.doi.org/10.1007/s10875-019-00651-2
_version_ 1783432756533919744
author Lowe, David M.
Smith, Philip J.
Moreira, Fernando
Workman, Sarita
Braggins, Helen
Koukias, Nikolaos
Buckland, Matthew S.
Wylie, Peter
Taylor, Stuart A.
Murray, Charles D.
author_facet Lowe, David M.
Smith, Philip J.
Moreira, Fernando
Workman, Sarita
Braggins, Helen
Koukias, Nikolaos
Buckland, Matthew S.
Wylie, Peter
Taylor, Stuart A.
Murray, Charles D.
author_sort Lowe, David M.
collection PubMed
description PURPOSE: Colitis is a common and serious complication of chronic granulomatous disorder (CGD) and requires assessment. Colonoscopy is invasive and carries risks of serious complication. We therefore assessed non-invasive monitoring via magnetic resonance imaging (MRI). We also evaluated fecal calprotectin (FCP), the Harvey-Bradshaw index (HBI) clinical score, and serum cytokines. METHODS: We recruited 10 patients with CGD (8 males, mean age 29.6 years), scored a modified HBI, and obtained stool for FCP. The following day we took blood for cytokine measurement via Luminex, performed MR enterography (scored by two independent radiologists using three systems: London score, CDMI, and MaRIA) followed by colonoscopy with disease activity measurement via ulcerative colitis endoscopic index of severity (UCEIS). We assessed patient experience after each investigation and overall preference with follow-up questionnaires. RESULTS: MRI scores correlated well with colonoscopic gold standard (for London score R(2) 0.91, p < 0.0001; for CDMI R(2) 0.83, p = 0.0006; for MaRIA R(2) 0.89, p = 0.0002). MRI was better tolerated and generally preferred, quicker, and visualized the entire large bowel whereas colonoscopy did not reach the terminal ileum in 3 participants. Elevated FCP accurately differentiated patients with colitis from those without, and log(calprotectin) correlated well with disease activity (R(2) 0.71, p = 0.009). Serum interleukin (IL)-12 concentration correlated with colitis activity but IL-1β and TNF did not. Harvey-Bradshaw index did not correlate with colitis activity. CONCLUSIONS: MRI and fecal calprotectin are useful methods for monitoring CGD colitis and should reduce the need for colonoscopy in these patients. IL-12 may represent an appropriate target for treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10875-019-00651-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6611758
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-66117582019-07-19 Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level Lowe, David M. Smith, Philip J. Moreira, Fernando Workman, Sarita Braggins, Helen Koukias, Nikolaos Buckland, Matthew S. Wylie, Peter Taylor, Stuart A. Murray, Charles D. J Clin Immunol Original Article PURPOSE: Colitis is a common and serious complication of chronic granulomatous disorder (CGD) and requires assessment. Colonoscopy is invasive and carries risks of serious complication. We therefore assessed non-invasive monitoring via magnetic resonance imaging (MRI). We also evaluated fecal calprotectin (FCP), the Harvey-Bradshaw index (HBI) clinical score, and serum cytokines. METHODS: We recruited 10 patients with CGD (8 males, mean age 29.6 years), scored a modified HBI, and obtained stool for FCP. The following day we took blood for cytokine measurement via Luminex, performed MR enterography (scored by two independent radiologists using three systems: London score, CDMI, and MaRIA) followed by colonoscopy with disease activity measurement via ulcerative colitis endoscopic index of severity (UCEIS). We assessed patient experience after each investigation and overall preference with follow-up questionnaires. RESULTS: MRI scores correlated well with colonoscopic gold standard (for London score R(2) 0.91, p < 0.0001; for CDMI R(2) 0.83, p = 0.0006; for MaRIA R(2) 0.89, p = 0.0002). MRI was better tolerated and generally preferred, quicker, and visualized the entire large bowel whereas colonoscopy did not reach the terminal ileum in 3 participants. Elevated FCP accurately differentiated patients with colitis from those without, and log(calprotectin) correlated well with disease activity (R(2) 0.71, p = 0.009). Serum interleukin (IL)-12 concentration correlated with colitis activity but IL-1β and TNF did not. Harvey-Bradshaw index did not correlate with colitis activity. CONCLUSIONS: MRI and fecal calprotectin are useful methods for monitoring CGD colitis and should reduce the need for colonoscopy in these patients. IL-12 may represent an appropriate target for treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10875-019-00651-2) contains supplementary material, which is available to authorized users. Springer US 2019-06-06 2019 /pmc/articles/PMC6611758/ /pubmed/31172380 http://dx.doi.org/10.1007/s10875-019-00651-2 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Lowe, David M.
Smith, Philip J.
Moreira, Fernando
Workman, Sarita
Braggins, Helen
Koukias, Nikolaos
Buckland, Matthew S.
Wylie, Peter
Taylor, Stuart A.
Murray, Charles D.
Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level
title Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level
title_full Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level
title_fullStr Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level
title_full_unstemmed Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level
title_short Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level
title_sort chronic granulomatous disorder–associated colitis can be accurately evaluated with mri scans and fecal calprotectin level
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611758/
https://www.ncbi.nlm.nih.gov/pubmed/31172380
http://dx.doi.org/10.1007/s10875-019-00651-2
work_keys_str_mv AT lowedavidm chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT smithphilipj chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT moreirafernando chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT workmansarita chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT bragginshelen chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT koukiasnikolaos chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT bucklandmatthews chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT wyliepeter chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT taylorstuarta chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel
AT murraycharlesd chronicgranulomatousdisorderassociatedcolitiscanbeaccuratelyevaluatedwithmriscansandfecalcalprotectinlevel